Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
TEGs – T cells retrovirally engineered to express a defined γδT cell receptor

Proposed period of release:
01/01/2016 to 01/01/2040

Name of the Institute(s) or Company(ies)
Universitair Medisch Centrum Utrecht (UMCU), Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands;

3. Is the same GMO release planned elsewhere in the Community?
Austria; Belgium; Germany; Denmark; Spain; Finland; France; United Kingdom; Greece; Ireland; Italy; Luxembourg; Portugal; Sweden; Iceland; Norway;

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Allogeneic or autologous human T cells retrovirally transduced with a replication- deficient derived viral vector (pMP71, isolated from a murine Moloney Murine Leukemia Virus) to express a yδTCR of human origin

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known